LORD, ABBETT & CO. LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$19,431,000
-26.3%
375,399
+3.5%
0.07%
-1.4%
Q1 2022$26,361,000
-76.5%
362,750
-61.7%
0.07%
-72.5%
Q4 2021$111,954,000
-20.6%
946,834
-9.9%
0.26%
-24.3%
Q3 2021$140,965,000
-2.3%
1,050,799
+17.9%
0.34%
-3.2%
Q2 2021$144,245,000
+164.7%
890,900
+31.2%
0.35%
+150.4%
Q1 2021$54,504,000
+1438.4%
679,141
+155.9%
0.14%
+1058.3%
Q3 2019$3,543,000
-23.6%
265,382
-6.3%
0.01%
-20.0%
Q2 2019$4,638,000
-24.4%
283,286
-21.1%
0.02%
-25.0%
Q1 2019$6,133,000
+79.5%
359,028
+43.5%
0.02%
+66.7%
Q4 2018$3,416,000
-27.7%
250,203
+51.6%
0.01%
-7.7%
Q3 2018$4,725,000165,0790.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders